Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur J Med Chem ; 149: 22-29, 2018 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-29494842

RESUMEN

Nowadays, the pharmacological therapy for the treatment of Chagas disease is based on two old drugs, benznidazole and nifurtimox, which have restricted efficacy against the chronic phase of the illness. To overcome the lack of efficacy of the traditional drugs (and their considerable toxicity), new molecular targets have been studied as starting points to the discovery of new antichagasic compounds. Among them, polyamine transporter TcPAT12 (also known as TcPOT1.1) represents an interesting macromolecule, since polyamines are essential for Trypanosoma cruzi, the parasite that causes the illness, but it cannot synthesize them de novo. In this investigation we report the results of a combined ligand- and structure-based virtual screening for the discovery of new inhibitors of TcPAT12. Initially we filtered out ZINC and Drugbank databases with similarity and QSAR models and then we submitted the candidates to a validated docking based screening. Four structures were selected and tested in T. cruzi epimastigotes proliferation and two of them, Cisapride and [2-(cyclopentyloxy)phenyl]methanamine showed inhibitory effects. Additionally, we performed transport assays which demonstrated that Cisapride interferes with putrescine uptake in a specific mode.


Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Cisaprida/farmacología , Proteínas Protozoarias/antagonistas & inhibidores , Putrescina/antagonistas & inhibidores , Trypanosoma cruzi/efectos de los fármacos , Transporte Biológico/efectos de los fármacos , Cisaprida/uso terapéutico , Evaluación Preclínica de Medicamentos/métodos , Ligandos , Proteínas de Transporte de Membrana/efectos de los fármacos , Simulación del Acoplamiento Molecular/métodos , Estructura Molecular , Poliaminas/farmacocinética , Putrescina/farmacocinética , Trypanosoma cruzi/metabolismo
2.
J Inorg Biochem ; 162: 207-215, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26723537

RESUMEN

Cultures of Shewanella putrefaciens grown in medium containing 10mM 1,4-diamino-2-butanone (DBO) as an inhibitor of ornithine decarboxylase and 10mM 1,5-diaminopentane (cadaverine) showed the simultaneous biosynthesis of the macrocyclic dihydroxamic acids: putrebactin (pbH2), avaroferrin (avH2) and bisucaberin (bsH2). The level of DBO did not completely repress the production of endogenous 1,4-diaminobutane (putrescine) as the native diamine substrate of pbH2. The relative concentration of pbH2:avH2:bsH2 was 1:2:1, which correlated with the substrate selection of putrescine:cadaverine in a ratio of 1:1. The macrocycles were characterised using LC-MS as free ligands and as 1:1 complexes with Fe(III) of the form [Fe(pb)]+, [Fe(av)]+ or [Fe(bs)]+, with labile ancillary ligands in six-coordinate complexes displaced during ESI-MS acquisition; or with Mo(VI) of the form [Mo(O)2(pb)], [Mo(O)2(av)] or [Mo(O)2(bs)]. Chromium(V) complexes of the form [CrO(pb)]+ were detected from solutions of Cr(VI) and pbH2 in DMF using X-band EPR spectroscopy. Supplementation of S. putrefaciens medium with DBO and 1,3-diaminopropane, 1,6-diaminohexane or 1,4-diamino-2(Z)-butene (Z-DBE) resulted only in the biosynthesis of pbH2. The work has identified a native system for the simultaneous biosynthesis of a suite of three macrocyclic dihydroxamic acid siderophores and highlights both the utility of precursor-directed biosynthesis for expanding the structural diversity of siderophores, and the breadth of their coordination chemistry.


Asunto(s)
Cromo/química , Hierro/química , Molibdeno/química , Péptidos Cíclicos/biosíntesis , Putrescina/análogos & derivados , Shewanella putrefaciens/metabolismo , Proteínas Bacterianas/antagonistas & inhibidores , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Cadaverina/metabolismo , Complejos de Coordinación/química , Diaminas/farmacología , Espectroscopía de Resonancia por Spin del Electrón , Expresión Génica , Ácidos Hidroxámicos/antagonistas & inhibidores , Ornitina Descarboxilasa/genética , Ornitina Descarboxilasa/metabolismo , Inhibidores de la Ornitina Descarboxilasa/farmacología , Péptidos Cíclicos/antagonistas & inhibidores , Putrescina/antagonistas & inhibidores , Putrescina/biosíntesis , Putrescina/farmacología , Shewanella putrefaciens/efectos de los fármacos , Shewanella putrefaciens/genética , Succinatos/antagonistas & inhibidores
3.
Lik Sprava ; (5): 133-9, 2012.
Artículo en Ucraniano | MEDLINE | ID: mdl-23534282

RESUMEN

This paper deals with antitumor properties of a fenugreek (Trigonella Foenum Graecum L.) as to the different genesis tumors--the Ca755 mouse mammary carcinoma and the Guerin's carcinoma in rats. Fenugreek powder was shown to inhibit (25-40 %) growth of certain tumors, decrease (27-63%) level of malone dialdehyde in liver, heart and kidney. Consumption of fenugreek was accompanied with decreased polyamines (spermine, spermidine, putrescine) content in tumor tissue. Inclusion of fenugreek to allowance was shown to improve certain blood value.


Asunto(s)
Antineoplásicos Fitogénicos/uso terapéutico , Carcinoma/tratamiento farmacológico , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Fitoterapia , Preparaciones de Plantas/uso terapéutico , Polvos/uso terapéutico , Trigonella/química , Animales , Antineoplásicos Fitogénicos/farmacología , Carcinoma/metabolismo , Cisplatino/administración & dosificación , Doxorrubicina/administración & dosificación , Resistencia a Antineoplásicos/efectos de los fármacos , Femenino , Corazón/efectos de los fármacos , Riñón/efectos de los fármacos , Riñón/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Malondialdehído/metabolismo , Neoplasias Mamarias Experimentales/metabolismo , Ratones , Extractos Vegetales/administración & dosificación , Preparaciones de Plantas/farmacología , Polvos/farmacología , Putrescina/antagonistas & inhibidores , Ratas , Espermidina/antagonistas & inhibidores , Espermina/antagonistas & inhibidores , Carga Tumoral/efectos de los fármacos
4.
Biochem Int ; 24(4): 633-40, 1991 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1799365

RESUMEN

The determination of diamine oxidase activity with the ninhydrin reagent was used for monitoring of simultaneous oxidation of two homologous substrates, putrescine and cadaverine, which give different colour products (519 and 417 nm). We measured the reaction rates of oxidation of both substrates in different proportion and compared them with the total reaction rate determined by the guaiacol method. The substrates show competition with inhibition constants of putrescine against cadaverine of 0.14 mmol.l-1 and cadaverine against putrescine of 6.4 mumol.l-1.


Asunto(s)
Amina Oxidasa (conteniendo Cobre)/metabolismo , Cadaverina/metabolismo , Putrescina/metabolismo , Unión Competitiva , Cadaverina/antagonistas & inhibidores , Fabaceae , Cinética , Oxidación-Reducción , Plantas Medicinales , Putrescina/antagonistas & inhibidores , Análisis Espectral , Especificidad por Sustrato
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA